These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21457505)

  • 1. Heparin-induced thrombocytopenia in the ICU: an overview.
    Sakr Y
    Crit Care; 2011; 15(2):211. PubMed ID: 21457505
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonheparin anticoagulants for heparin-induced thrombocytopenia.
    Kelton JG; Arnold DM; Bates SM
    N Engl J Med; 2013 Feb; 368(8):737-44. PubMed ID: 23425166
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice. Heparin-induced thrombocytopenia.
    Arepally GM; Ortel TL
    N Engl J Med; 2006 Aug; 355(8):809-17. PubMed ID: 16928996
    [No Abstract]   [Full Text] [Related]  

  • 6. Fondaparinux in acute heparin-induced thrombocytopenia: a case series.
    Goldfarb MJ; Blostein MD
    J Thromb Haemost; 2011 Dec; 9(12):2501-3. PubMed ID: 21883881
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenic but effective: the HIT-fondaparinux brain puzzler.
    Greinacher A
    J Thromb Haemost; 2011 Dec; 9(12):2386-8. PubMed ID: 21929685
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 9. Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Jul; 100(1):168-9; author reply 169-70. PubMed ID: 18612559
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.
    Warkentin TE; Greinacher A; Gruel Y; Aster RH; Chong BH;
    J Thromb Haemost; 2011 Dec; 9(12):2498-500. PubMed ID: 22947414
    [No Abstract]   [Full Text] [Related]  

  • 11. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches to the diagnosis of heparin-induced thrombocytopenia.
    Warkentin TE
    Chest; 2005 Feb; 127(2 Suppl):35S-45S. PubMed ID: 15706029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
    Salem M; Elrefai S; Shrit MA; Warkentin TE
    Thromb Haemost; 2010 Nov; 104(5):1071-2. PubMed ID: 20806120
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin release assay (SRA)-negative HIT, a newly recognized entity: Implications for diagnosis and management.
    Pandya KA; Johnson EG; Davis GA; Padmanabhan A
    Thromb Res; 2018 Dec; 172():169-171. PubMed ID: 30419472
    [No Abstract]   [Full Text] [Related]  

  • 16. Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU.
    Harada MY; Hoang DM; Zaw AA; Murry JS; Volod O; Sun BJ; Nuño M; Mason R; Margulies DR; Ley EJ
    Crit Care Med; 2017 Jan; 45(1):28-34. PubMed ID: 27513533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient pseudothrombocytopenia associated with immune heparin-induced thrombocytopenia complicated by pulmonary embolism.
    Zimrin AB; Warkentin TE
    Thromb Haemost; 2013 May; 109(5):971-3. PubMed ID: 23636478
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia.
    Warkentin TE; Sheppard JI; Moore JC; Kelton JG
    J Thromb Haemost; 2010 Jan; 8(1):216-8. PubMed ID: 19818000
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia.
    Lee GM; Arepally GM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():668-74. PubMed ID: 24319250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiology of heparin-induced thrombocytopenia.
    Sandset PM
    Curr Top Microbiol Immunol; 2010; 341():193-202. PubMed ID: 20369319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.